AMHD.US HLK Biotech Holding Group Inc
- Market cap
- USD 1.39K
- P/E
- -
- P/B
- -
- ROE
- -7.1%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2017.
Is AMHD.US undervalued?
Graham numberThe Graham number of HLK Biotech Holding Group Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
HLK Biotech Holding Group Inc fundamental analysis
No fundamental analysis for HLK Biotech Holding Group Inc yet.
HLK Biotech Holding Group Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About HLK Biotech Holding Group Inc
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.
Full company profileHLK Biotech Holding Group Inc financial statements
2017 annualized: Fiscal year 2017 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2017, the balance sheet is the latest quarter. Figures change when the annual report is published.
HLK Biotech Holding Group Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1997 | 1998 | 2014 | 2015 | 2016 | 2017 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 0.00 | 0.00 | 18.1K | 12.2K | 8.33K | 3.09K |
| Gross Profit | 0.00 | -180K | 18.1K | 12.2K | 8.33K | 3.09K |
| Operating Income | -962K | -707K | -11.4K | -3.12K | -912.00 | -3.09K |
| Net Income | -962K | -1.04M | -19.1K | 1.00 | -3.77K | -3.49K |
| EPS | - | - | - | - | - | 0.00 |
| Balance Sheet | ||||||
| Total Assets | 60.9K | 852K | 121K | 117K | 117K | 112K |
| Total Liabilities | 41.0K | 1.48M | 65.7K | 61.2K | 64.8K | 63.1K |
| Shareholders' Equity | 19.9K | -623K | 55.7K | 55.7K | 51.9K | 49.3K |
| Cash & Short-term Investments | 870.00 | 63.4K | 84.00 | 5.00 | 2.40K | - |
| Cash Flow | ||||||
| Operating Cash Flow | -1.37M | -442K | -16.5K | 2.57K | -1.21K | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Ratios | ||||||
| ROE | -4,839.3% | - | -34.3% | 0.0% | -7.3% | -7.1% |
| ROA | -1,579.7% | -121.8% | -15.7% | 0.0% | -3.2% | -3.1% |
| Net Profit Margin | - | - | -105.5% | 0.0% | -45.3% | -112.7% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
HLK Biotech Holding Group Inc dividends
HLK Biotech Holding Group Inc has not paid dividends in the last 5 fiscal years.
Last stock split: 1:1000 on Feb 23, 2018.
Who owns HLK Biotech Holding Group Inc
Ownership data of HLK Biotech Holding Group Inc is not available yet.
HLK Biotech Holding Group Inc company profile
- Company name
- HLK Biotech Holding Group Inc
- Ticker
- AMHD.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Pharmaceuticals
- Fiscal year end
- December
- Address
- 2612 Granby Street, Norfolk, VA, United States, 23517
- Phone
- 646 926 3568
- Website
- amelotholdings.com
About HLK Biotech Holding Group Inc
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. It also acquires real estate properties. The company was formerly known as Amelot Holdings, Inc. and changed its name to HLK Biotech Holding Group, Inc. in February 2018. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia.
HLK Biotech Holding Group Inc management
6- Dr. Anna PetinovaInterim Vice President of Administration, Interim Vice President of Finance, Treasurer and Director · born 1964
- Mr. Hank MiddenVice President - Operations · born 1942
- Mr. John GernanntHead of Investor & Public Relations Issues
- Mr. Peter R. N. MaharajVice President - Marketing and President - Southern Hardwoods · born 1966
- Mr. Thomas CripeSenior Vice President of Business & Technology Development
- Mr. Tyler MacallisterController